CAS 870262-90-1: Letaxaban
Description:Letaxaban, identified by its CAS number 870262-90-1, is an investigational anticoagulant that belongs to the class of direct factor Xa inhibitors. It is designed to prevent thrombus formation by selectively inhibiting factor Xa, an essential enzyme in the coagulation cascade. Letaxaban exhibits high oral bioavailability and a predictable pharmacokinetic profile, which allows for fixed dosing without the need for routine monitoring of anticoagulation levels. The substance is characterized by its relatively short half-life, which may necessitate regular dosing to maintain therapeutic effects. In preclinical and clinical studies, Letaxaban has demonstrated efficacy in reducing the risk of venous thromboembolism and other thrombotic events. Its safety profile is still under investigation, but like other anticoagulants, it may carry risks of bleeding. Overall, Letaxaban represents a promising option in the field of anticoagulation therapy, with ongoing research aimed at fully elucidating its therapeutic potential and safety.
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Letaxaban REF: 54-BUP03872CAS: 870262-90-1 | 99% | 1,519.00 €~5,140.00 € | Thu 24 Apr 25 |
 | Letaxaban REF: TM-T68092CAS: 870262-90-1 | 98.68% - 99.01% | 200.00 €~2,072.00 € | Thu 24 Apr 25 |
 | Letaxaban REF: 3D-FL24871CAS: 870262-90-1 | Min. 95% | To inquire | Tue 06 May 25 |
Ref: 54-BUP03872
| 25mg | 1,519.00 € | ||
| 50mg | 2,084.00 € | ||
| 100mg | 2,804.00 € | ||
| 500mg | 5,140.00 € |
Letaxaban
Ref: TM-T68092
| 1mg | 200.00 € | ||
| 5mg | 513.00 € | ||
| 10mg | 740.00 € | ||
| 25mg | 1,121.00 € | ||
| 50mg | 1,539.00 € | ||
| 100mg | 2,072.00 € |
Letaxaban
Ref: 3D-FL24871
| Undefined size | To inquire |
